Background Image
Previous Page  156 / 182 Next Page
Information
Show Menu
Previous Page 156 / 182 Next Page
Page Background

155

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

31

Burton AW, Driver LC, Mendoza TR, Syed G. Oral transmucosal fentanyl citrate in the

outpatient management of severe cancer pain crises: a retrospective case series. Clini-

cal Journal of Pain 2004; 20: 195-197.

32

Burton AW, Reddy SK, Shah HN, Tremont-Lukats I, Mendel E. Percutaneous vertebro-

plasty – a technique to treat refractory spinal pain in the setting of advanced metastatic

cancer: a case series. Journal of Pain and Symptom Management 2005; 30: 87-95.

33

Burton B, Zeppetella G. Assessing the impact of breakthrough cancer pain. Br J Nurs

2011; 20(10): S14, S16-19.

34

Callstrom MR, Charboneau JW, Goetz MP, Rubin J, Atwell TD, Farrell MA, Welch TJ,

Maus TP. Image-guided ablation of painful metastatic bone tumors: a new and effective

approach to a difficult problem. Skeletal Radiology 2006; 35: 1-15.

35

Caraceni A, Cherny N, Fainsinger R, Kaasa S, Poulain P, Radbruch L, De Conno F. Pain

measurement tools and methods in clinical research in palliative care: recommen-

dations of an Expert Working Group of the European Association of Palliative Care.

Journal of Pain and Symptom Management 2002; 23: 239-255.

36

Caraceni A, Martini C, Zecca E, Portenoy RK, Ashby MA, Hawson G, Jackson KA, Lickiss

N, Muirden N, Pisasale M, Moulin D, Schulz VN, Rico Pazo MA, Serrano JA, Andersen H,

Henriksen HT, Mejholm I, Sjogren P, Heiskanen T, Kalso E, Pere P, Poyhia R, Vuorinen E,

Tigerstedt I, Ruismaki P, Bertolino M, Larue F, Ranchere JY, Hege-Scheuing G, Bowdler I,

Helbing F, Kostner E, Radbruch L, Kastrinaki K, Shah S, Vijayaram S, Sharma KS, Devi PS,

Jain PN, Ramamani PV, Beny A, Brunelli C, Maltoni M, Mercadante S, Plancarte R, Schug

S, Engstrand P, Ovalle AF, Wang X, Alves MF, Abrunhosa MR, Sun WZ, Zhang L, Gazizov

A, Vaisman M, Rudoy S, Gomez Sancho M, Vila P, Trelis J, Chaudakshetrin P, Koh ML,

Van Dongen RT, Vielvoye-Kerkmeer A, Boswell MV, Elliott T, Hargus E, Lutz L; Working

Group of an IASP Task Force on Cancer Pain. Breakthrough pain characteristics and

syndromes in patients with cancer pain. An international survey. Palliative Medicine

2004; 18(3): 177-183.

37

Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and

syndromes. Pain 1999; 82(3): 263-274.

38

Carr DB, Goudas LC, Denman WT, Brookoff D, Staats PS, Brennan L, et al. Safety and

efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with

chronic pain: a randomized, double-blind, placebo-controlled, crossover study. Pain

2004; 108: 17-27.

39

Casuccio A, Mercadante S, Fulfaro F. Treatment strategies for cancer patients with

breakthrough pain. Expert Opin Pharmacother 2009; 10(6): 947-953.

40

Christelis N, Filshie J. Other therapeutic interventions. In: Davies A (Hrsg.), Cancer-rela-

ted breakthrough pain. Oxford: Oxford University Press; 2006, 97-110.

41

Christie JM, Simmonds M, Patt R, Coluzzi P, Busch MA, Nordbrock E, et al. Dose-

titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of

breakthrough pain in cancer patients using transdermal fentanyl for persistent pain.

Journal of Clinical Oncology 1998; 16: 3238-3245.

Literaturverzeichnis